Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 669-678

  Zhang, Yong Tai ^a   Shen, Li Na ^a   Zhao, Ji Hui ^a   Feng, Nian Ping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Absorption enhancer; Formulation vehicle; Nanocarriers; Nanoparticles; Transdermal

Indexed keywords

ABSORPTION ENHANCER; FORMULATION VEHICLE; NANOCARRIERS; NANOPARTICLES; TRANSDERMAL;

ADMINISTRATION, TOPICAL; ANIMALS; ETHANOL; FICUSIN; LIPOSOMES; MALE; MICRODIALYSIS; NANOCAPSULES; RADIATION-SENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; TISSUE DISTRIBUTION;

EID: 84893490078     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57314     Document Type: Article

References (34)

1. Ada S, Güleç AT, Tülin Güleç A. CD8+ poikilodermatous mycosis fungoides with a nonaggressive clinical behaviour and a good response to psoralen plus ultraviolet A treatment. Br J Dermatol. 2007;157(5): 1064-1066.
2. Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol. 2012;51(9):1107-1115.
3. Stern RS. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med. 2007;357(7):682-690.
4. Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14(2):87-109.
5. Bacigalupi RM, Postolova A, Davis RS. Evidence-based, non-surgical treatments for vitiligo: a review. Am J Clin Dermatol. 2012;13(4): 217-237.
6. Umar N, Yamamoto S, Loerbroks A, Terris D. Elicitation and use of patients' preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol. 2012;92(4):341-346.
7. Ozkan I, Köse O, Ozmen I, Arca E. Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque- type psoriasis. Int J Dermatol. 2012;51(5):609-613.
8. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64(5):936-949.
9. Nagase K, Hirashima N, Koba S, Inoue T, Misago N, Narisawa Y. Acquired dermal melanocytosis induced by psoralen plus ultraviolet A therapy. Acta Derm Venereol. 2012;92(6):691-692.
10. Stern RS; PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553-562.
11. Choi MJ, Maibach HI. Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci. 2005;27(4):211-221.
12. Pierre MB, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch {Eth}ermatol Res. 2011;303(9):607-621.
13. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65(3):403-418.
14. Ainbinder D, Paolino D, Fresta M, Touitou E. Drug delivery applications with ethosomes. J Biomed Nanotechnol. 2010;6(5):558-568.
15. Nanda A, Nanda S, Ghilzai NM. Current developments using emerging transdermal technologies in physical enhancement methods. Curr Drug Deliv. 2006;3(3):233-242.
16. Ajazuddin, Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81(7):680-689.
17. Chen JG, Liu YF, Gao TW. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model. J Liposome Res. 2010;20(4): 297-303.
18. Gupta U, Jain NK. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Adv Drug Deliv Rev. 2010;62(4-5):478-490.
19. Zhang Z, Wo Y, Zhang Y, et al. In vitro study of ethosome penetration in human skin and hypertrophic scar tissue. Nanomedicine. 2012;8(6): 1026-1033.
20. Zhang X, Liu L, Zhang X, et al. Analytical methods for brain targeted delivery system in vivo: perspectives on imaging modalities and microdialysis. J Pharm Biomed Anal. 2012;59:1-12.
21. Cheng GW, Hsu KC, Lee CF, Wu HL, Huang YL. On-line microdialysis coupled with liquid chromatography for biomedical analysis. J Chromatogr Sci. 2009;47(8):624-630.
22. Holmgaard R, Nielsen JB, Benfeldt E. Microdialysis sampling for investigations of bioavailability and bioequivalence of topically admin- istered drugs: current state and future perspectives. Skin Pharmacol Physiol. 2010;23(5):225-243.
23. Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm Res. 2001;18(3): 367-373.
24. Maestrelli F, Capasso G, González-Rodríguez ML, Rabasco AM, Ghelardini C, Mura P. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res. 2009;19(4):253-260.
25. Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007;67(2):398-405.
26. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1-2):99-110.
27. Fang YP, Tsai YH, Wu PC, Huang YB. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 2008;356(1-2):144-152.
28. Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: An overview. J Adv Pharm Technol Res. 2010;1(3): 274-282.
29. Celia C, Cilurzo F, Trapasso E, Cosco D, Fresta M, Paolino D. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices. 2012;14(1):119-130.
30. Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 2007;123(2):148-154.
31. Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm Sci Tech. 2007;8(4):E111.
32. Rao Y, Zheng F, Zhang X, Gao J, Liang W. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS Pharm Sci Tech. 2008;9(3):860-865.
33. Mills PC, Cross SE. Regional differences in the in vitro penetration of hydrocortisone through equine skin. J Vet Pharmacol Ther. 2006;29(1): 25-30.
34. Mills PC, Magnusson BM, Cross SE. Investigation of in vitro transder- mal absorption of fentanyl from patches placed on skin samples obtained from various anatomic regions of dogs. Am J Vet Res. 2004;65(12): 1697-1700.